Fresenius Medical Care AG (FRA:FME)

Fresenius Medical Care AG Statistics

Total Valuation

FRA:FME has a market cap or net worth of EUR 13.47 billion. The enterprise value is 23.86 billion.

Market Cap	13.47B
Enterprise Value	23.86B

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	May 23, 2025

Share Statistics

Current Share Class	289.84M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	41.51%
Float	205.93M

Valuation Ratios

The trailing PE ratio is 20.53 and the forward PE ratio is 11.17.

PE Ratio	20.53
Forward PE	11.17
PS Ratio	0.69
PB Ratio	0.94
P/TBV Ratio	n/a
P/FCF Ratio	6.58
P/OCF Ratio	4.89
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.45, with an EV/FCF ratio of 11.65.

EV / Earnings	36.35
EV / Sales	1.22
EV / EBITDA	7.45
EV / EBIT	13.66
EV / FCF	11.65

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.77.

Current Ratio	1.44
Quick Ratio	0.87
Debt / Equity	0.77
Debt / EBITDA	3.64
Debt / FCF	5.39
Interest Coverage	4.03

Financial Efficiency

Return on equity (ROE) is 5.72% and return on invested capital (ROIC) is 3.78%.

Return on Equity (ROE)	5.72%
Return on Assets (ROA)	3.03%
Return on Invested Capital (ROIC)	3.78%
Return on Capital Employed (ROCE)	6.17%
Revenue Per Employee	173,579
Profits Per Employee	5,838
Employee Count	111,513
Asset Turnover	0.60
Inventory Turnover	6.96

Taxes

In the past 12 months, FRA:FME has paid 316.84 million in taxes.

Income Tax	316.84M
Effective Tax Rate	27.29%

Stock Price Statistics

The stock price has increased by +19.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+19.85%
50-Day Moving Average	44.08
200-Day Moving Average	45.66
Relative Strength Index (RSI)	61.72
Average Volume (20 Days)	243

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:FME had revenue of EUR 19.52 billion and earned 656.42 million in profits. Earnings per share was 2.23.

Revenue	19.52B
Gross Profit	4.81B
Operating Income	1.58B
Pretax Income	1.16B
Net Income	656.42M
EBITDA	2.36B
EBIT	1.58B
Earnings Per Share (EPS)	2.23

Balance Sheet

The company has 1.72 billion in cash and 11.04 billion in debt, giving a net cash position of -9.33 billion.

Cash & Cash Equivalents	1.72B
Total Debt	11.04B
Net Cash	-9.33B
Net Cash Per Share	n/a
Equity (Book Value)	14.33B
Book Value Per Share	45.23
Working Capital	2.48B

Cash Flow

In the last 12 months, operating cash flow was 2.75 billion and capital expenditures -706.18 million, giving a free cash flow of 2.05 billion.

Operating Cash Flow	2.75B
Capital Expenditures	-706.18M
Free Cash Flow	2.05B
FCF Per Share	n/a

Margins

Gross margin is 24.67%, with operating and profit margins of 8.10% and 3.36%.

Gross Margin	24.67%
Operating Margin	8.10%
Pretax Margin	5.95%
Profit Margin	3.36%
EBITDA Margin	12.10%
EBIT Margin	8.10%
FCF Margin	10.49%

Dividends & Yields

This stock pays an annual dividend of 1.44, which amounts to a dividend yield of 3.08%.

Dividend Per Share	1.44
Dividend Yield	3.08%
Dividend Growth (YoY)	21.01%
Years of Dividend Growth	1
Payout Ratio	64.37%
Buyback Yield	n/a
Shareholder Yield	3.08%
Earnings Yield	4.87%
FCF Yield	15.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 18, 2007. It was a forward split with a ratio of 3.

Last Split Date	Jun 18, 2007
Split Type	Forward
Split Ratio	3

Scores

FRA:FME has an Altman Z-Score of 1.83 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.83
Piotroski F-Score	6